The 2014 Updated Guidelines: Improved
Treatment of Atrial Fibrillation and Stroke

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live webinars on September 24, 2014 and October 3, 2014. If you participated in the live webinars, you are not eligible for continuing education credits from this archive.

This activity is valid from January 15, 2015 to January 31, 2016

Instructions for CME: Listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. A score of 70% must be achieved on the post test to receive continuing education credits. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate. It is best to save your certificate. You will need to click on the “download” button and choose save.

These presentations require Adobe Flash Player.  You can download it here.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Boehringer-Ingelheim



Preventing blood clots (thromboembolism), and thus strokes, may be the most important part of treating atrial fibrillation. The AHA/ACC/HRS Updated Guidelines for Stroke Prevention in Atrial Fibrillation were released in March 2014. There is also a new recommendation on a more comprehensive thromboembolic risk calculator to estimate stroke risk, the CHA2DS2-VASc calculator. Dr. Boyle will discuss the need for stroke prevention, review the newly released 2014 AHA/ACC/HRS guidelines and describe the new risk calculator.

Upon Completion of this activity, participants will be able to:

  • Discuss the CHA2DS2-VASc thromboembolic risk calculator

  • Describe the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation recommendations regarding stroke prevention

  • Evaluate management strategies to improve adherence to anticoagulation therapies

  • Analyze the efficacy and safety of current and emerging anticoagulants and stroke prevention treatments

Faculty: Noel G. Boyle, MD, PhD
UCLA Cardiac Arrhythmia Center
Ronald Reagan UCLA Medical Center


Dr. Boyle has no financial relationships to disclose.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from Boehringer-Ingelheim

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.